Slapak, E.J.; el Mandili, M.; Brink, M.S.T.; Kros, A.; Bijlsma, M.F.; Spek, C.A.
Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer. Int. J. Mol. Sci. 2023, 24, 10704.
https://doi.org/10.3390/ijms241310704
AMA Style
Slapak EJ, el Mandili M, Brink MST, Kros A, Bijlsma MF, Spek CA.
Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer. International Journal of Molecular Sciences. 2023; 24(13):10704.
https://doi.org/10.3390/ijms241310704
Chicago/Turabian Style
Slapak, Etienne J., Mouad el Mandili, Marieke S. Ten Brink, Alexander Kros, Maarten F. Bijlsma, and C. Arnold Spek.
2023. "Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer" International Journal of Molecular Sciences 24, no. 13: 10704.
https://doi.org/10.3390/ijms241310704
APA Style
Slapak, E. J., el Mandili, M., Brink, M. S. T., Kros, A., Bijlsma, M. F., & Spek, C. A.
(2023). Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer. International Journal of Molecular Sciences, 24(13), 10704.
https://doi.org/10.3390/ijms241310704